Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:2761-2768
Published online before print July 9, 2009, doi: 10.1161/STROKEAHA.108.544957
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/8/2761    most recent
STROKEAHA.108.544957v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Embolic stroke
Right arrow Emergency treatment of Stroke
Right arrow Other Stroke
Right arrowRelated Article

(Stroke. 2009;40:2761.)
© 2009 American Heart Association, Inc.


Original Contributions

The Penumbra Pivotal Stroke Trial

Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease

The Penumbra Pivotal Stroke Trial Investigators

From Penumbra Inc, Alameda, Calif.

Correspondence to Siu Po Sit, PhD, Penumbra Inc, 1351 Harbor Bay Parkway, Alameda, CA 94502. E-mail siupo.sit{at}penumbrainc.com

Background and Purpose— The purpose of this clinical evaluation was to assess the safety and effectiveness of the Penumbra System in the revascularization of patients presenting with acute ischemic stroke secondary to intracranial large vessel occlusive disease.

Methods— In this prospective, multicenter, single-arm study, 125 patients with neurological deficits as defined by a National Institutes of Health Stroke Scale score ≥8, presented within 8 hours of symptom onset, and an angiographic occlusion (Thrombolysis In Myocardial Infarction [TIMI] Grade 0 or 1) of a treatable large intracranial vessel were enrolled. Patients who presented within 3 hours from symptom onset had to be ineligible or refractory to recombinant tissue plasminogen activator therapy. All patients were followed clinically for 90 days postprocedure.

Results— A total of 125 target vessels in 125 patients were treated by the Penumbra System. Postprocedure, 81.6% of the treated vessels were successfully revascularized to TIMI 2 to 3. There were 18 procedural events reported in 16 patients (12.8%), 3 patients (2.4%) had events that were considered serious. A total of 35 patients (28%) were found to have intracranial hemorrhage on 24-hour CT of which 14 (11.2%) were symptomatic. All cause mortality was 32.8% at 90 days with 25% of the patients achieving a modified Rankin Scale score of ≤2.

Conclusions— These results suggest the Penumbra System allows safe and effective revascularization in patients experiencing ischemic stroke secondary to large vessel occlusive disease who present within 8 hours from symptom onset.


Key Words: mechanical thrombectomy • patient outcome • revascularization • stroke


Related Article:

When Recanalization Does Not Improve Clinical Outcomes
Shelagh B. Coutts and Mayank Goyal
Stroke 2009 40: 2661. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
S. B. Coutts and M. Goyal
When Recanalization Does Not Improve Clinical Outcomes
Stroke, August 1, 2009; 40(8): 2661 - 2661.
[Full Text] [PDF]